Committees

Committees

The Management Advisory Committee (MAC)

The general affairs of the ALTG are overseen by the Management Advisory Committee (MAC) which is elected by members and chaired by the ALTG President. The MAC meets every 3 months via teleconference or Face-to-Face. Some of these meetings are open to all ALTG members. If you would like to know the dates of  future open MAC meetings, please visit the Events’ page.

Get to know this committee by reading the biography of the MAC members.

Scientific Advisory Committee (SAC)

The advisory committee to the MAC is called the Scientific Advisory Committee (SAC). The SAC assists investigators in the development of new study proposals, oversees ongoing studies and advises the MAC on scientific matters that may arise. Usually the SAC meets every 3 months via teleconference or Face-to-Face in conjunction with the MAC. Some of these meetings are open to all ALTG members. To see the dates of the future open SAC meetings, please visit the Events’ page.

Get to know this committee by reading the biography of the SAC members.

Concept development working groups

The ALTG convenes working groups of consumers and health professionals reflecting the multidisciplinary membership to assist with review and development of clinical trial concepts. These were previously referred to as SAC subgroups and have recently undergone a restructure to be renamed as concept development working groups.

The working groups’ role is to:

  • Develop and/or review new research concepts and grant applications
  • Identify gaps in research activities and the clinical trial portfolio and actively encourage the submission of concepts to fill this gap

The ALTG concept development working groups are:

  1. Early NSCLC
  2. Advanced NSCLC
  3. SCLC, mesothelioma and other thymic cancers

In addition, the ALTG convenes a supportive care panel that provides input into developing concepts.

Submit an EOI to join a concept development working group here

The Consumer Advisory Panel (CAP)

The ALTG recognises the importance of consumer involvement in the design of clinical trials that will improve outcomes for patients and has formed the ALTG CAP to provide a consumer perspective on issues related to clinical trials. Key activities include input into clinical trial design, review of new trial concepts, identification of gaps in research and review of trial patient information and consent forms.

Get to know this committee by reading the biography of the CAP members.

If you would like to take part of an ALTG advisory committee, please contact us so we can discuss this further.